Managing patients with high risk breast lesions

Sarah Anwar, MDLinx

San Antonio Breast Cancer Symposium 2017

San Antonio, Texas, United States | December 05-09, 2017

Amy C. Degnim, MD, professor of surgery, Mayo Clinic, Rochester, MN, discusses the different management strategies for lesions that put patients at increased risk for breast cancer.

“There’s no right or wrong choice in managing risk, it’s really just a discussion between the provider and patient to understand what their risk is, and understand the options for managing that risk and figuring out what is the best fit for that patient.”

In some cases, excising the lesion is the best course of action. However, it is important to gauge the risk of cancer so as to avoid unnecessary excisions.

All Interviews

From this Conference

2:14

Breast cancer: Where we were and how far we’ve come
Over the past few decades, great progress has been made in the field of breast cancer, according to Tatiana Prowell, MD, breast cancer scientific liaison, FDA Oncology Center...
Tatiana Prowell, MD
4:23

Circulating tumor cells as prognostic biomarkers for recurrence of breast cancer
At the 2018 Best of San Antonio Breast Cancer Symposium-New York, Joseph Sparano, MD, professor of medicine and women’s health, Albert Einstein College of Medicine,...
Joseph A. Sparano, MD
2:34

Estrogen receptor expression in luminal tumors & recurrence and metastasis
Luminal breast cancer subtypes are characterized by estrogen-receptor and estrogen-related genes, which sets them apart from other tumors that are not hormonally driven.
Angela DeMichele, MD, MSCE

1:50

Conversion to response after failed immunotherapy
In some patients with cancer who have failed immune checkpoint blockade treatment, the addition of radiotherapy may bring about conversion to response.
Silvia Formenti, MD
1:50

Tumor types, immune response, and radiotherapy
One of the most exciting areas of study currently being conducted in breast cancer is the potential of radiation therapy to convert tumors into an in situ vaccine. Silvia...
Silvia Formenti, MD
1:47

Evaluating the risk of breast cancer among female patients
There are several factors that put female patients at an increased risk for breast cancer.
Amy C. Degnim, MD

This activity is not sanctioned by, nor a part of, the San Antonio Breast Cancer Symposium 2017.